Respivant Sciences GmbH
2 clinical trials · Sponsor
◉ Watch Respivant Sciences GmbH
| Record | Firm | Date |
|---|---|---|
| Open-label Study of Inhaled RVT-1601 in Preterm Infants (NCT04007120) | Respivant Sciences GmbH | 2019-10-01 |
| A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (NCT03864328) | Respivant Sciences GmbH | 2019-03-29 |
Track Respivant Sciences GmbH automatically
Every clearance here is in the API, with alerts when new ones post.